HedgeChatter

  • Home /
  • Tag Archives

NVS

Tokyo prosecutors raid Novartis Japan unit in probe: Kyodo

[Reuters] – Prosecutors in Tokyo raided the local unit of Swiss drugmaker Novartis (NOVN.VX) as part of an investigation into alleged use of manipulated data to promote its best-selling blood pressure drug Diovan, Kyodo News reported on Wednesday. Japan’ moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring […]

February 19, 2014 Bystocknews , Comments Off on Tokyo prosecutors raid Novartis Japan unit in probe: Kyodo read more

[$$] Tencent Invests in Restaurant-Rating App

[at The Wall Street Journal] – China’s price regulator said it has been conducting an antimonopoly investigation into Qualcomm Inc. and InterDigital Inc. of the U.S. since the middle of last year. moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click here to view […]

February 19, 2014 Bystocknews , Comments Off on [$$] Tencent Invests in Restaurant-Rating App read more

[$$] RBS Sells Markets Units to BNP

[at The Wall Street Journal] – China’s price regulator said it has been conducting an antimonopoly investigation into Qualcomm Inc. and InterDigital Inc. of the U.S. since the middle of last year. moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click here to view […]

February 19, 2014 Bystocknews , Comments Off on [$$] RBS Sells Markets Units to BNP read more

Novartis investigational compound LDE225 met primary endpoint in pivotal trial for patients with advanced basal cell carcinoma »

[at noodls] – Results showLDE225 achieved clinically significant tumor response including disappearance of the tumor in some patients within six months of treatment Basal cell carcinoma accounts for more than 80% of … moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click here to view […]

February 19, 2014 Bystocknews , Comments Off on Novartis investigational compound LDE225 met primary endpoint in pivotal trial for patients with advanced basal cell carcinoma » read more

Should Novartis Be in Your Portfolio?

moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click here to view […]

February 18, 2014 Bystocknews , Comments Off on Should Novartis Be in Your Portfolio? read more

Novartis expands cancer immunotherapy research program with acquisition of CoStim »

[at noodls] – Acquisition adds novel immune modulating targets and technology to accelerate Novartis cancer immunotherapy program Novartis and University of Pennsylvania CAR immunotherapy research combined with CoStim … moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click here to view […]

February 17, 2014 Bystocknews , Comments Off on Novartis expands cancer immunotherapy research program with acquisition of CoStim » read more